462 filings
6-K
SVA
Sinovac Biotech, Ltd.
29 Apr 24
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
6:12pm
20-F
2023 FY
SVA
Sinovac Biotech, Ltd.
Annual report (foreign)
29 Apr 24
4:30pm
SC 13G/A
Advantech Capital L.P.
20 Mar 24
SINOVAC BIOTECH / Advantech Capital ownership change
7:33am
SC TO-T/A
SVA
Sinovac Biotech, Ltd.
15 Mar 24
Third party tender offer statement (amended)
6:18pm
8-A12B/A
SVA
Sinovac Biotech, Ltd.
21 Feb 24
Registration of securities on exchange (amended)
6:09am
6-K
vvspqg9
21 Feb 24
Current report (foreign)
6:02am
SC TO-T/A
7sm1z27a 81gi8ees
2 Feb 24
Third party tender offer statement (amended)
11:19am
SC 14D9
i0twvpc1dubw25mrmlqq
18 Jan 24
Tender offer solicitation
7:13am
SC TO-T
50ohytx6j8kmcgd6
8 Jan 24
Third party tender offer statement
4:46pm
SC 13D/A
z0zcxr
4 Dec 23
SINOVAC BIOTECH / SAIF Partners IV ownership change
6:01am
UPLOAD
br5pc8a9n6a lf9q7rww
10 Oct 23
Letter from SEC
12:00am
CORRESP
ti5v4sammwl1
5 Oct 23
Correspondence with SEC
12:00am
SC TO-T/A
1psjjj eddes
3 Oct 23
Third party tender offer statement (amended)
9:39am
SC 13D/A
ypqepw5sp8jvy973
15 Sep 23
SINOVAC BIOTECH / SAIF Partners IV ownership change
8:59am
6-K
264reek
11 Sep 23
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
6:16am
UPLOAD
7hvl 2cde96ad
8 Sep 23
Letter from SEC
12:00am
SC 14D9
ebvd4bt61iizs9yi2h3
5 Sep 23
Tender offer solicitation
7:04am
CORRESP
gf29fi
1 Sep 23
Correspondence with SEC
12:00am
6-K
q5domsi4
29 Aug 23
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
6:05am
6-K
ye0dq7cytq
28 Aug 23
Sinovac Announces Change of Legal Representative of Sinovac Beijing
9:12am